CRSP
Price
$50.19
Change
+$0.90 (+1.83%)
Updated
Nov 21, 04:59 PM (EDT)
Capitalization
4.79B
88 days until earnings call
Intraday BUY SELL Signals
KYMR
Price
$66.20
Change
+$1.57 (+2.43%)
Updated
Nov 21, 04:59 PM (EDT)
Capitalization
4.64B
90 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRSP vs KYMR

Header iconCRSP vs KYMR Comparison
Open Charts CRSP vs KYMRBanner chart's image
CRISPR Therapeutics AG
Price$50.19
Change+$0.90 (+1.83%)
Volume$40.81K
Capitalization4.79B
Kymera Therapeutics
Price$66.20
Change+$1.57 (+2.43%)
Volume$49.35K
Capitalization4.64B
CRSP vs KYMR Comparison Chart in %
CRSP
Daily Signal:
Gain/Loss:
KYMR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRSP vs. KYMR commentary
Nov 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and KYMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 22, 2025
Stock price -- (CRSP: $49.29 vs. KYMR: $64.52)
Brand notoriety: CRSP and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 87% vs. KYMR: 83%
Market capitalization -- CRSP: $4.79B vs. KYMR: $4.64B
CRSP [@Biotechnology] is valued at $4.79B. KYMR’s [@Biotechnology] market capitalization is $4.64B. The market cap for tickers in the [@Biotechnology] industry ranges from $108.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, KYMR is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 4 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • CRSP’s TA Score: 4 bullish, 6 bearish.
  • KYMR’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than CRSP.

Price Growth

CRSP (@Biotechnology) experienced а -3.56% price change this week, while KYMR (@Biotechnology) price change was +1.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.93%. For the same industry, the average monthly price growth was -3.16%, and the average quarterly price growth was +63.47%.

Reported Earning Dates

CRSP is expected to report earnings on Feb 17, 2026.

KYMR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (-0.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($4.79B) and KYMR($4.64B) have the same market capitalization . KYMR YTD gains are higher at: 60.378 vs. CRSP (25.229). KYMR has higher annual earnings (EBITDA): -267.03M vs. CRSP (-533.5M). CRSP has more cash in the bank: 1.72B vs. KYMR (665M). KYMR has less debt than CRSP: KYMR (85.7M) vs CRSP (215M). KYMR has higher revenues than CRSP: KYMR (44.7M) vs CRSP (35M).
CRSPKYMRCRSP / KYMR
Capitalization4.79B4.64B103%
EBITDA-533.5M-267.03M200%
Gain YTD25.22960.37842%
P/E RatioN/AN/A-
Revenue35M44.7M78%
Total Cash1.72B665M259%
Total Debt215M85.7M251%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
71
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPKYMR
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 5 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 5 days ago
82%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend about 1 month ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CRSP
Daily Signal:
Gain/Loss:
KYMR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FVFRX54.92N/A
N/A
Franklin Small Cap Value R
LYRBX28.78N/A
N/A
Lyrical US Value Equity Investor
RMDCX3.33N/A
N/A
Virtus Silvant Mid-Cap Growth C
BSGIX15.29N/A
N/A
Baird Small/Mid Cap Growth Institutional
NFFFX93.97-1.19
-1.25%
American Funds New World F2

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-0.46%
NRIX - KYMR
64%
Loosely correlated
+6.98%
VERA - KYMR
61%
Loosely correlated
-2.38%
RGNX - KYMR
54%
Loosely correlated
-0.59%
IDYA - KYMR
54%
Loosely correlated
+0.09%
NUVL - KYMR
54%
Loosely correlated
+0.90%
More